Circulating FSCN1 may be somehow involved in tumor progression, namely in the metastatic process, as well as in tumor relapse, supported by the evidence that FSCN1 in pre-surgery samples is predictive of DFS but not of the OS. Here, FSCN1 is linked to neoplasm.